chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Blood lactic acid, COVID-19, Cerebrovascular accident, Chest X-ray normal, Full blood count abnormal
Clinical narrative: COVID Vaccine Breakthrough Case. Moderna Dose 1 2/17/21 (031L20A). Moderna Dose 2 3/17/21 (036A21A). COVID Negative 9/18/21. COVID Positive 9/28/2021. 9/28/21: A 76-year-old man with a history of myelodysplastic syndrome, hypertension, anxiety, recent CVA in the right middle cerebral artery distribution, right internal carotid artery stenosis who was discharged from local Medical Center on 09/22/2021 where he was managed for an acute CVA. Patient was discharged to the rehab unit, prior to discharge, COVID-19 screen done on 09/18 2021 was negative. Today while at the rehab unit he develops a fever T-max of 102.1 degrees. He is 96% on room air. Sepsis workup done, chest x-ray reveals no infiltrate, the lungs are clear. Urinalysis not suggestive of UTI. Lactic acid was 1.2.  CBC done reveals pancytopenia with WBC of 2000, platelet count of 33000 hemoglobin of 12.3. COVID-19 screen done on 09/28/2021 is positive. Patient transferred to local Medical Center for further evaluation. At time of evaluation, patient denies cough, no headaches, no diarrhea, abdominal pain or vomiting. No dysuria. 10/7/21: Patient is a 76-year-old male initially admitted to the hospital for left hemiparesis evaluation noted for ischemic CVA involving the right middle cerebral artery distribution patient was subsequently sent to acute rehab for further care, his acute rehab course was cut short due to positive COVID test result without any symptoms patient was subsequently transferred back to local hospital for further care. During the course of this hospitalization, patient continue to work with therapy, did not requiring any supplemental oxygen and did not have any respiratory distress. Patient was noted to have right index finger paronychia for which he was started on p.o. Keflex. Patient will be discharged home with antibiotic for completion, referred to VNA for RN, PT and OT.  Recommended follow-up with PCP within 1 week.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Haemoglobin decreased, Hemiparesis, Ischaemic cerebral infarction, Pancytopenia, Paronychia
Clinical narrative: COVID Vaccine Breakthrough Case. Moderna Dose 1 2/17/21 (031L20A). Moderna Dose 2 3/17/21 (036A21A). COVID Negative 9/18/21. COVID Positive 9/28/2021. 9/28/21: A 76-year-old man with a history of myelodysplastic syndrome, hypertension, anxiety, recent CVA in the right middle cerebral artery distribution, right internal carotid artery stenosis who was discharged from local Medical Center on 09/22/2021 where he was managed for an acute CVA. Patient was discharged to the rehab unit, prior to discharge, COVID-19 screen done on 09/18 2021 was negative. Today while at the rehab unit he develops a fever T-max of 102.1 degrees. He is 96% on room air. Sepsis workup done, chest x-ray reveals no infiltrate, the lungs are clear. Urinalysis not suggestive of UTI. Lactic acid was 1.2.  CBC done reveals pancytopenia with WBC of 2000, platelet count of 33000 hemoglobin of 12.3. COVID-19 screen done on 09/28/2021 is positive. Patient transferred to local Medical Center for further evaluation. At time of evaluation, patient denies cough, no headaches, no diarrhea, abdominal pain or vomiting. No dysuria. 10/7/21: Patient is a 76-year-old male initially admitted to the hospital for left hemiparesis evaluation noted for ischemic CVA involving the right middle cerebral artery distribution patient was subsequently sent to acute rehab for further care, his acute rehab course was cut short due to positive COVID test result without any symptoms patient was subsequently transferred back to local hospital for further care. During the course of this hospitalization, patient continue to work with therapy, did not requiring any supplemental oxygen and did not have any respiratory distress. Patient was noted to have right index finger paronychia for which he was started on p.o. Keflex. Patient will be discharged home with antibiotic for completion, referred to VNA for RN, PT and OT.  Recommended follow-up with PCP within 1 week.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Platelet count decreased, Pyrexia, SARS-CoV-2 test positive, Urine analysis normal, Vaccine breakthrough infection
Clinical narrative: COVID Vaccine Breakthrough Case. Moderna Dose 1 2/17/21 (031L20A). Moderna Dose 2 3/17/21 (036A21A). COVID Negative 9/18/21. COVID Positive 9/28/2021. 9/28/21: A 76-year-old man with a history of myelodysplastic syndrome, hypertension, anxiety, recent CVA in the right middle cerebral artery distribution, right internal carotid artery stenosis who was discharged from local Medical Center on 09/22/2021 where he was managed for an acute CVA. Patient was discharged to the rehab unit, prior to discharge, COVID-19 screen done on 09/18 2021 was negative. Today while at the rehab unit he develops a fever T-max of 102.1 degrees. He is 96% on room air. Sepsis workup done, chest x-ray reveals no infiltrate, the lungs are clear. Urinalysis not suggestive of UTI. Lactic acid was 1.2.  CBC done reveals pancytopenia with WBC of 2000, platelet count of 33000 hemoglobin of 12.3. COVID-19 screen done on 09/28/2021 is positive. Patient transferred to local Medical Center for further evaluation. At time of evaluation, patient denies cough, no headaches, no diarrhea, abdominal pain or vomiting. No dysuria. 10/7/21: Patient is a 76-year-old male initially admitted to the hospital for left hemiparesis evaluation noted for ischemic CVA involving the right middle cerebral artery distribution patient was subsequently sent to acute rehab for further care, his acute rehab course was cut short due to positive COVID test result without any symptoms patient was subsequently transferred back to local hospital for further care. During the course of this hospitalization, patient continue to work with therapy, did not requiring any supplemental oxygen and did not have any respiratory distress. Patient was noted to have right index finger paronychia for which he was started on p.o. Keflex. Patient will be discharged home with antibiotic for completion, referred to VNA for RN, PT and OT.  Recommended follow-up with PCP within 1 week.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: White blood cell count increased
Clinical narrative: COVID Vaccine Breakthrough Case. Moderna Dose 1 2/17/21 (031L20A). Moderna Dose 2 3/17/21 (036A21A). COVID Negative 9/18/21. COVID Positive 9/28/2021. 9/28/21: A 76-year-old man with a history of myelodysplastic syndrome, hypertension, anxiety, recent CVA in the right middle cerebral artery distribution, right internal carotid artery stenosis who was discharged from local Medical Center on 09/22/2021 where he was managed for an acute CVA. Patient was discharged to the rehab unit, prior to discharge, COVID-19 screen done on 09/18 2021 was negative. Today while at the rehab unit he develops a fever T-max of 102.1 degrees. He is 96% on room air. Sepsis workup done, chest x-ray reveals no infiltrate, the lungs are clear. Urinalysis not suggestive of UTI. Lactic acid was 1.2.  CBC done reveals pancytopenia with WBC of 2000, platelet count of 33000 hemoglobin of 12.3. COVID-19 screen done on 09/28/2021 is positive. Patient transferred to local Medical Center for further evaluation. At time of evaluation, patient denies cough, no headaches, no diarrhea, abdominal pain or vomiting. No dysuria. 10/7/21: Patient is a 76-year-old male initially admitted to the hospital for left hemiparesis evaluation noted for ischemic CVA involving the right middle cerebral artery distribution patient was subsequently sent to acute rehab for further care, his acute rehab course was cut short due to positive COVID test result without any symptoms patient was subsequently transferred back to local hospital for further care. During the course of this hospitalization, patient continue to work with therapy, did not requiring any supplemental oxygen and did not have any respiratory distress. Patient was noted to have right index finger paronychia for which he was started on p.o. Keflex. Patient will be discharged home with antibiotic for completion, referred to VNA for RN, PT and OT.  Recommended follow-up with PCP within 1 week.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Patient was given the child vaccine from ages 5-11 y/o and the patient is 13 years old  0.3  ml
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphagia, Throat tightness
Clinical narrative: Patient came in with history of idiopathic anaphylactic reaction. Pre-medicated with Benadryl 25mg PO at home. Received 2nd Pfizer injection at 3:00 pm. Approximately 15 minutes post administration slight throat tightness. Vital signs stable. BP: 160/60; HR: 71; O2: 98. Received Benadryl 25mg IM at 15:40. 2nd set of vitals: BP: 140/90; HR: 78; O2: 100. Continued to monitor. Patient stated she did not feel better after 15 minutes after the Benadryl injection. No complaint of any new symptoms. Vitals 20 min post Benadryl IM: BP: 158/60; HR:79; O2:100. Difficulty swallowing and worsening of throat tightness. EpiPen injected at 4:11 pm in left thigh. Vitals before administering EpiPen: O2: 100; pulse: 79; BP: 158/60. The ambulance was called and arrived at 4:15 pm. The patient stated she was not feeling better after EpiPen; therefore Solumedrol IV administered. Patient taken to the hospital at 4:30 pm. Vitals at the moment of hospitalization O2: 98; pulse: 85; BP 135/90.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature increased, Discomfort, Gait disturbance, Inflammation, Pain
Clinical narrative: I noticed swellness in my foot, and I had difficulty walking around. It got to the point I was not going up and down my stairs or getting up from my chair. I went to the doctor and he looked at my foot and he prescribed 10mg Prendizone (steroid). I took that and the inflammation subsided. It got to a more acceptable level. I now take Tylenol for the pain and discomfort and I am not sure if it will resolve. I am not even sure if it is related to the vaccine. However, I am not fully functional as I was before the booster vaccine.  Also to note my temperature never goes above 98 degrees. It didn't with any vaccine I have ever taken, and neither with the first 2. However with the booster, I did have a slightly elevated temperature which I found odd. Nothing to major, but odd since I never have a higher temperature.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: I noticed swellness in my foot, and I had difficulty walking around. It got to the point I was not going up and down my stairs or getting up from my chair. I went to the doctor and he looked at my foot and he prescribed 10mg Prendizone (steroid). I took that and the inflammation subsided. It got to a more acceptable level. I now take Tylenol for the pain and discomfort and I am not sure if it will resolve. I am not even sure if it is related to the vaccine. However, I am not fully functional as I was before the booster vaccine.  Also to note my temperature never goes above 98 degrees. It didn't with any vaccine I have ever taken, and neither with the first 2. However with the booster, I did have a slightly elevated temperature which I found odd. Nothing to major, but odd since I never have a higher temperature.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Asymptomatic COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Lung opacity, SARS-CoV-2 test positive
Clinical narrative: asymptomatic COVID-19 leading to hospitalization after 2 doses of Moderna: COVID-19 infection COVID-19 pneumonia Date of onset of symptoms: 1/17/2022 Date of covid positive test and admission to ED: 1/21/2022 Vaccination status: vaccinated Imaging: CXR 1/21 showed patchy bibasilar opacities  Oxygen requirements on admission: 2-3L Current oxygen requirements: 3-L Medical therapy: remdesivir, steroids, rocephin and zithromax discontinued Anticipated special isolation end date: 1/31/2022 Was ready for discharge ; cancelled due to V tach  plans to get booster 2/14/22
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Ventricular tachycardia
Clinical narrative: asymptomatic COVID-19 leading to hospitalization after 2 doses of Moderna: COVID-19 infection COVID-19 pneumonia Date of onset of symptoms: 1/17/2022 Date of covid positive test and admission to ED: 1/21/2022 Vaccination status: vaccinated Imaging: CXR 1/21 showed patchy bibasilar opacities  Oxygen requirements on admission: 2-3L Current oxygen requirements: 3-L Medical therapy: remdesivir, steroids, rocephin and zithromax discontinued Anticipated special isolation end date: 1/31/2022 Was ready for discharge ; cancelled due to V tach  plans to get booster 2/14/22
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: pt given vaccine on 1/15/22 that had a BUD of 1/9/22.  Pt offered revaccination per CDC guidelines. No adverse events/reactions
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Blindness, Dizziness, Head discomfort, Hypotension, Vomiting
Clinical narrative: Once the patient received the vaccine, after 2-3 minutes, he felt dizzy and I asked him to sit down. He went on to say that his head feels heavy and he could no longer see. He drank water and wanted to laid down. Right after he vomited and was escorted by paramedics to the hospital as his blood pressure was very low.
Age: 87.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood creatinine increased, Blood lactic acid decreased, Blood potassium normal, Blood sodium increased, Blood urea increased
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/5/2021 and 2/26/2021. Presented to ED on 1/15/2022 with complaints of rectal bleeding and SOB. Admited for acute hypoxemic respiratory distress due to Covid PNA. In ED, noted to be borderline hypotensive and hypoxic at 87%. Placed on BiPAP and his O2 improved. Labs revealed significant metabolic derangements including creatinine 6.24, BUN 120, CO2 18, sodium 160 but K was normal. Lactate was 1.1 and WBC was 5.9. Non-contrast CT chest confirms GGO consistent with Covid pneumonia. Treated with azithromycin, rocephin, and decadron. DNAR status. Expired on 1/26/22.
Age: 87.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Carbon dioxide decreased, Computerised tomogram thorax abnormal, Death
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/5/2021 and 2/26/2021. Presented to ED on 1/15/2022 with complaints of rectal bleeding and SOB. Admited for acute hypoxemic respiratory distress due to Covid PNA. In ED, noted to be borderline hypotensive and hypoxic at 87%. Placed on BiPAP and his O2 improved. Labs revealed significant metabolic derangements including creatinine 6.24, BUN 120, CO2 18, sodium 160 but K was normal. Lactate was 1.1 and WBC was 5.9. Non-contrast CT chest confirms GGO consistent with Covid pneumonia. Treated with azithromycin, rocephin, and decadron. DNAR status. Expired on 1/26/22.
Age: 87.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Hypotension, Hypoxia, Lung opacity, Positive airway pressure therapy
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/5/2021 and 2/26/2021. Presented to ED on 1/15/2022 with complaints of rectal bleeding and SOB. Admited for acute hypoxemic respiratory distress due to Covid PNA. In ED, noted to be borderline hypotensive and hypoxic at 87%. Placed on BiPAP and his O2 improved. Labs revealed significant metabolic derangements including creatinine 6.24, BUN 120, CO2 18, sodium 160 but K was normal. Lactate was 1.1 and WBC was 5.9. Non-contrast CT chest confirms GGO consistent with Covid pneumonia. Treated with azithromycin, rocephin, and decadron. DNAR status. Expired on 1/26/22.
Age: 87.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Rectal haemorrhage, Respiratory distress, SARS-CoV-2 test positive, White blood cell count normal
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/5/2021 and 2/26/2021. Presented to ED on 1/15/2022 with complaints of rectal bleeding and SOB. Admited for acute hypoxemic respiratory distress due to Covid PNA. In ED, noted to be borderline hypotensive and hypoxic at 87%. Placed on BiPAP and his O2 improved. Labs revealed significant metabolic derangements including creatinine 6.24, BUN 120, CO2 18, sodium 160 but K was normal. Lactate was 1.1 and WBC was 5.9. Non-contrast CT chest confirms GGO consistent with Covid pneumonia. Treated with azithromycin, rocephin, and decadron. DNAR status. Expired on 1/26/22.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Electroencephalogram abnormal, Encephalopathy, Endotracheal intubation, Hypoxia
Clinical narrative: Admitted on 1/18 for right lower leg amputation on 1/20. Found to be COVID positive. Developed some hypoxia and 1/19 requiring O2.   Decline in mental status and found to be in PEA arrest and underwent 4 rounds of ACLS before ROSC was obtained. Intubated and transferred to critical care. Unable to tolerate hemodialysis and found to have myoclonus. EEG showed evidence of severe encephalopathy. Family requested comfort care.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Intensive care, Leg amputation, Life support, Mental status changes, Myoclonus
Clinical narrative: Admitted on 1/18 for right lower leg amputation on 1/20. Found to be COVID positive. Developed some hypoxia and 1/19 requiring O2.   Decline in mental status and found to be in PEA arrest and underwent 4 rounds of ACLS before ROSC was obtained. Intubated and transferred to critical care. Unable to tolerate hemodialysis and found to have myoclonus. EEG showed evidence of severe encephalopathy. Family requested comfort care.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pulseless electrical activity, SARS-CoV-2 test positive
Clinical narrative: Admitted on 1/18 for right lower leg amputation on 1/20. Found to be COVID positive. Developed some hypoxia and 1/19 requiring O2.   Decline in mental status and found to be in PEA arrest and underwent 4 rounds of ACLS before ROSC was obtained. Intubated and transferred to critical care. Unable to tolerate hemodialysis and found to have myoclonus. EEG showed evidence of severe encephalopathy. Family requested comfort care.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Amputation, COVID-19, Cardiac arrest, Death, Dry gangrene
Clinical narrative: Admitted on 1/18 for right lower leg amputation on 1/20. Found to be COVID positive. Developed some hypoxia and 1/19 requiring O2.   Decline in mental status and found to be in PEA arrest and underwent 4 rounds of ACLS before ROSC was obtained. Intubated and transferred to critical care. Unable to tolerate hemodialysis and found to have myoclonus. EEG showed evidence of severe encephalopathy. Family requested comfort care.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Encephalopathy, Endotracheal intubation, Hypoxia, Impaired healing, Life support
Clinical narrative: Admitted on 1/18 for right lower leg amputation on 1/20. Found to be COVID positive. Developed some hypoxia and 1/19 requiring O2.   Decline in mental status and found to be in PEA arrest and underwent 4 rounds of ACLS before ROSC was obtained. Intubated and transferred to critical care. Unable to tolerate hemodialysis and found to have myoclonus. EEG showed evidence of severe encephalopathy. Family requested comfort care.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Mental status changes, Pulseless electrical activity, SARS-CoV-2 test positive
Clinical narrative: Admitted on 1/18 for right lower leg amputation on 1/20. Found to be COVID positive. Developed some hypoxia and 1/19 requiring O2.   Decline in mental status and found to be in PEA arrest and underwent 4 rounds of ACLS before ROSC was obtained. Intubated and transferred to critical care. Unable to tolerate hemodialysis and found to have myoclonus. EEG showed evidence of severe encephalopathy. Family requested comfort care.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Anticoagulant therapy, Blood test, Bundle branch block right, COVID-19
Clinical narrative: COVID Vaccine Breakthrough Case. Pfizer Dose 1- 3/5/21 (EN6206). Pfizer Dose 2- 3/25/21 (ER8732). COVID Positive 10/31/21. 10/31/21: This is a 78 years old gentleman with a history of coronary artery disease status post stents, ischemic cardiomyopathy with ejection fraction in the 20s%, presents to the emergency department at County Hospital due to difficulty breathing and cough. The patient states that the symptoms started about 4 days ago and are getting worse. There is no associated exacerbating or relieving factors. Denies recent travel or sick contact that he can recall. Denies recent weight gain, lower extremity swelling. The patient currently denies shortness of breath and chest pain. On lab work he was found to have acute kidney injury as well as elevated D-dimer and a positive COVID test. Patient is reportedly vaccinated against COVID with Moderna vaccines last year.  Due to the abnormalities in the lab work patient was recommended to transfer to our facility to undergo V/Q scan to evaluate for PE given the elevated D-dimer. He was started empirically on IV heparin in the ED. EKG shows a right bundle branch block, patient without complaint of chest pain however does have an elevated troponin level at 0.04 in the setting of acute kidney injury. 11/4/21: Patient was admitted to this hospital to undergo V/Q scan which the County hospital did not have the capacity to perform, this resulted low probability for PE. Patient was initially on heparin prior to transfer to our campus, this was discontinued after V/Q scan result. Patient was on Lovenox sub-Q for VTE prophylaxis while undergoing treatment for COVID-19 pneumonia with antiviral and antibiotic therapy as well as steroids due to transient need for O2 supplementation via nasal cannula. Home medications were resumed.  He was given gentle IV fluids with subsequent improvement in renal function. He was advised strongly to follow up with his PCP and repeat blood work to monitor renal function. Plan of care was discussed in detail with patient and he expressed understanding and agreement. He was seen and examined on the day of discharge, states he is doing very well and is very eager to be discharged home. Total time spent on discharge 45 minutes. Patient discharged in stable conditions.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Cough, Dyspnoea, Electrocardiogram abnormal, Fibrin D dimer increased
Clinical narrative: COVID Vaccine Breakthrough Case. Pfizer Dose 1- 3/5/21 (EN6206). Pfizer Dose 2- 3/25/21 (ER8732). COVID Positive 10/31/21. 10/31/21: This is a 78 years old gentleman with a history of coronary artery disease status post stents, ischemic cardiomyopathy with ejection fraction in the 20s%, presents to the emergency department at County Hospital due to difficulty breathing and cough. The patient states that the symptoms started about 4 days ago and are getting worse. There is no associated exacerbating or relieving factors. Denies recent travel or sick contact that he can recall. Denies recent weight gain, lower extremity swelling. The patient currently denies shortness of breath and chest pain. On lab work he was found to have acute kidney injury as well as elevated D-dimer and a positive COVID test. Patient is reportedly vaccinated against COVID with Moderna vaccines last year.  Due to the abnormalities in the lab work patient was recommended to transfer to our facility to undergo V/Q scan to evaluate for PE given the elevated D-dimer. He was started empirically on IV heparin in the ED. EKG shows a right bundle branch block, patient without complaint of chest pain however does have an elevated troponin level at 0.04 in the setting of acute kidney injury. 11/4/21: Patient was admitted to this hospital to undergo V/Q scan which the County hospital did not have the capacity to perform, this resulted low probability for PE. Patient was initially on heparin prior to transfer to our campus, this was discontinued after V/Q scan result. Patient was on Lovenox sub-Q for VTE prophylaxis while undergoing treatment for COVID-19 pneumonia with antiviral and antibiotic therapy as well as steroids due to transient need for O2 supplementation via nasal cannula. Home medications were resumed.  He was given gentle IV fluids with subsequent improvement in renal function. He was advised strongly to follow up with his PCP and repeat blood work to monitor renal function. Plan of care was discussed in detail with patient and he expressed understanding and agreement. He was seen and examined on the day of discharge, states he is doing very well and is very eager to be discharged home. Total time spent on discharge 45 minutes. Patient discharged in stable conditions.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Laboratory test abnormal, SARS-CoV-2 test positive, Troponin, Vaccine breakthrough infection, Ventilation/perfusion scan
Clinical narrative: COVID Vaccine Breakthrough Case. Pfizer Dose 1- 3/5/21 (EN6206). Pfizer Dose 2- 3/25/21 (ER8732). COVID Positive 10/31/21. 10/31/21: This is a 78 years old gentleman with a history of coronary artery disease status post stents, ischemic cardiomyopathy with ejection fraction in the 20s%, presents to the emergency department at County Hospital due to difficulty breathing and cough. The patient states that the symptoms started about 4 days ago and are getting worse. There is no associated exacerbating or relieving factors. Denies recent travel or sick contact that he can recall. Denies recent weight gain, lower extremity swelling. The patient currently denies shortness of breath and chest pain. On lab work he was found to have acute kidney injury as well as elevated D-dimer and a positive COVID test. Patient is reportedly vaccinated against COVID with Moderna vaccines last year.  Due to the abnormalities in the lab work patient was recommended to transfer to our facility to undergo V/Q scan to evaluate for PE given the elevated D-dimer. He was started empirically on IV heparin in the ED. EKG shows a right bundle branch block, patient without complaint of chest pain however does have an elevated troponin level at 0.04 in the setting of acute kidney injury. 11/4/21: Patient was admitted to this hospital to undergo V/Q scan which the County hospital did not have the capacity to perform, this resulted low probability for PE. Patient was initially on heparin prior to transfer to our campus, this was discontinued after V/Q scan result. Patient was on Lovenox sub-Q for VTE prophylaxis while undergoing treatment for COVID-19 pneumonia with antiviral and antibiotic therapy as well as steroids due to transient need for O2 supplementation via nasal cannula. Home medications were resumed.  He was given gentle IV fluids with subsequent improvement in renal function. He was advised strongly to follow up with his PCP and repeat blood work to monitor renal function. Plan of care was discussed in detail with patient and he expressed understanding and agreement. He was seen and examined on the day of discharge, states he is doing very well and is very eager to be discharged home. Total time spent on discharge 45 minutes. Patient discharged in stable conditions.
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Abdominal discomfort, Asthenia, Body temperature fluctuation, Body temperature increased, Chest discomfort
Clinical narrative: 1st dose   core  temp felt cold  for approx 2 weeks 2nd dose 5:00 pm feeling  a little off; 7:00 pm had severe body convulsions  between and 1-2minutes; felt really cold  and weak; approx 930 pm took temp up to 105.5 for the next 48  hours  it  fluctuated  between 100- 105.5. i had bad  "brain fog" severe  for 8 days; started having  headache and still have  several headaches  a day some  are mild some are  very intense, some are a few  minutes some are  hours long, still having today; i have had  burning  and tightness  in my  chest and abdomen, it was  contstant for the first  4 weeks, then off and on through the day, along with the burning i have had nasuea and acid  reflux with minimal vomiting; continued below
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Fatigue, Feeling abnormal, Feeling cold, Gastrooesophageal reflux disease
Clinical narrative: 1st dose   core  temp felt cold  for approx 2 weeks 2nd dose 5:00 pm feeling  a little off; 7:00 pm had severe body convulsions  between and 1-2minutes; felt really cold  and weak; approx 930 pm took temp up to 105.5 for the next 48  hours  it  fluctuated  between 100- 105.5. i had bad  "brain fog" severe  for 8 days; started having  headache and still have  several headaches  a day some  are mild some are  very intense, some are a few  minutes some are  hours long, still having today; i have had  burning  and tightness  in my  chest and abdomen, it was  contstant for the first  4 weeks, then off and on through the day, along with the burning i have had nasuea and acid  reflux with minimal vomiting; continued below
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Headache, Mental impairment, Muscle spasms, Nausea, Seizure
Clinical narrative: 1st dose   core  temp felt cold  for approx 2 weeks 2nd dose 5:00 pm feeling  a little off; 7:00 pm had severe body convulsions  between and 1-2minutes; felt really cold  and weak; approx 930 pm took temp up to 105.5 for the next 48  hours  it  fluctuated  between 100- 105.5. i had bad  "brain fog" severe  for 8 days; started having  headache and still have  several headaches  a day some  are mild some are  very intense, some are a few  minutes some are  hours long, still having today; i have had  burning  and tightness  in my  chest and abdomen, it was  contstant for the first  4 weeks, then off and on through the day, along with the burning i have had nasuea and acid  reflux with minimal vomiting; continued below
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Somnolence, Vomiting
Clinical narrative: 1st dose   core  temp felt cold  for approx 2 weeks 2nd dose 5:00 pm feeling  a little off; 7:00 pm had severe body convulsions  between and 1-2minutes; felt really cold  and weak; approx 930 pm took temp up to 105.5 for the next 48  hours  it  fluctuated  between 100- 105.5. i had bad  "brain fog" severe  for 8 days; started having  headache and still have  several headaches  a day some  are mild some are  very intense, some are a few  minutes some are  hours long, still having today; i have had  burning  and tightness  in my  chest and abdomen, it was  contstant for the first  4 weeks, then off and on through the day, along with the burning i have had nasuea and acid  reflux with minimal vomiting; continued below
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: on 1/15/22 pt received vaccine of 1/9/22. No adverse reactions.  Offered revaccinations per CDC guidelines
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Pharyngeal swelling
Clinical narrative: Pt described swelling to throat, chest tightness
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac monitoring, Dyspnoea, Fatigue, Feeling cold, Hypoaesthesia
Clinical narrative: I am an officer. The day I received the first shot I had a hard crash of fatigue. Not a big deal, but it didn't stop. Since day 1 I've had fatigue that won't go away, shortness of breath, and absolutely terrible circulation to all four limbs. My legs have gone completely numb on more than one occasion and both hands/feet appear blue.   I've had tingling (similar to what your arm feels like if you hook your arm over a chair while sitting and put the chair's back right into your armpit) in both arms from the shoulders down to the fingertips, but mainly below the elbows. Sleeping on my side has proven difficult due to the sensation of no circulation. My legs have the exact same thing.   I am cold all the time----and I've never had this problem my entire life.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Paraesthesia, Poor peripheral circulation, Skin discolouration
Clinical narrative: I am an officer. The day I received the first shot I had a hard crash of fatigue. Not a big deal, but it didn't stop. Since day 1 I've had fatigue that won't go away, shortness of breath, and absolutely terrible circulation to all four limbs. My legs have gone completely numb on more than one occasion and both hands/feet appear blue.   I've had tingling (similar to what your arm feels like if you hook your arm over a chair while sitting and put the chair's back right into your armpit) in both arms from the shoulders down to the fingertips, but mainly below the elbows. Sleeping on my side has proven difficult due to the sensation of no circulation. My legs have the exact same thing.   I am cold all the time----and I've never had this problem my entire life.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Blood test, Chest X-ray, Dyspnoea, Electrocardiogram
Clinical narrative: I got SOB and I went into an Acute Respiratory Failure. I had to be hospitalized. My oxygen was only at 50%. They did chest X-ray, sleep study, blood work, EKG, and urine sample.  I am on several different medicines now.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Sleep study, Urine analysis
Clinical narrative: I got SOB and I went into an Acute Respiratory Failure. I had to be hospitalized. My oxygen was only at 50%. They did chest X-ray, sleep study, blood work, EKG, and urine sample.  I am on several different medicines now.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Cough, Dyspnoea, Dyspnoea exertional
Clinical narrative: COVID Positive 10/6/21 Hospitalized 10/6/21-10/10/21 Pfizer Dose 1 10/21/21 (EWO217) - note, received vaccine while COVID Positive COVID Positive 10/22/21 COVID Positive 10/23/21  10/19/21: This 52-year-old gentleman presented to the emergency room with complaint of shortness of breath and fever that started a few days ago.  The patient reports shortness of breath, worse with activities. He has a mild cough.  He was recently admitted and treated for COVID pneumonia, and discharged on the October 10, 2021.  On that admission, the patient declined remdesivir treatment.  In the emergency room patient was noted to have some degree of hypoxia and currently is on 6 L of oxygen via nasal cannula.  11/8/21:  Patient has informed me that he wishes to leave against medical advise.  I have discussed all risks associated with this decision including but not limited to respiratory failure renal failure multi organ failure and death.  He endorses understanding he is lucid alert and oriented x3 and responding appropriately.  Again informed him that we are awaiting final recommendations of his transfer team, Nephrology and he will likely need O2 walk as well.  He refuses to stay and wishes to sign out.  Nursing appraised and aware of situation.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: COVID Positive 10/6/21 Hospitalized 10/6/21-10/10/21 Pfizer Dose 1 10/21/21 (EWO217) - note, received vaccine while COVID Positive COVID Positive 10/22/21 COVID Positive 10/23/21  10/19/21: This 52-year-old gentleman presented to the emergency room with complaint of shortness of breath and fever that started a few days ago.  The patient reports shortness of breath, worse with activities. He has a mild cough.  He was recently admitted and treated for COVID pneumonia, and discharged on the October 10, 2021.  On that admission, the patient declined remdesivir treatment.  In the emergency room patient was noted to have some degree of hypoxia and currently is on 6 L of oxygen via nasal cannula.  11/8/21:  Patient has informed me that he wishes to leave against medical advise.  I have discussed all risks associated with this decision including but not limited to respiratory failure renal failure multi organ failure and death.  He endorses understanding he is lucid alert and oriented x3 and responding appropriately.  Again informed him that we are awaiting final recommendations of his transfer team, Nephrology and he will likely need O2 walk as well.  He refuses to stay and wishes to sign out.  Nursing appraised and aware of situation.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Patient received Pfizer COVID-19 vaccine which was beyond the manufacturer recommended use time of 31 days at the refrigerated temperature. Organization has been in direct contact with the vaccine manufacturer regarding this issue. Pfizer has data to support the stability of the vaccine up to 45 days at refrigerated temperatures. The vaccine given was within this range which is supported by the above data. No known adverse outcomes.
Age: 58.0
Sex: U
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Death, Endotracheal intubation, Renal impairment
Clinical narrative: Moderna COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccines on 01/29/21, 3/6/2021 and 9/23/2021. COVID + on 1/11/22. Presented to ED on 1/16/2022, intubated and sedated after being found unresponsive at home with O2 in 50s. Recently discharged on 2.5L NC from outside facility for COVID PNA (1/11 - 1/15).  Treated with solumedrol, rocephin, and remdesivir at outside facility. Once admitted, found to have complicated UTI with stenotrophomonas maltophilia and Serratia rubidaea. treated with cefepime then ceftriaxone. Renal function continued to worsen despite treatments and supportive measures. DNAR. Expired 1/27/22.
Age: 58.0
Sex: U
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Serratia infection, Stenotrophomonas infection, Unresponsive to stimuli, Urinary tract infection
Clinical narrative: Moderna COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccines on 01/29/21, 3/6/2021 and 9/23/2021. COVID + on 1/11/22. Presented to ED on 1/16/2022, intubated and sedated after being found unresponsive at home with O2 in 50s. Recently discharged on 2.5L NC from outside facility for COVID PNA (1/11 - 1/15).  Treated with solumedrol, rocephin, and remdesivir at outside facility. Once admitted, found to have complicated UTI with stenotrophomonas maltophilia and Serratia rubidaea. treated with cefepime then ceftriaxone. Renal function continued to worsen despite treatments and supportive measures. DNAR. Expired 1/27/22.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Breast swelling, Breast tenderness, Lymphadenopathy
Clinical narrative: Left-sided breast tenderness. Increased breast size and lymphadenopathy noted.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Took Moderna for first 2 doses of Covid vaccine. Received Pfizer vaccine for booster. Itching all over body.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine diluted with sodium chloride 0.9% (expired 1/1/2022). Pfizer manufactured the diluent and had no stability data past expiration date, therefore in the absence of this data, said to re-dose the vaccine.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, Chest X-ray abnormal, Death, Dyspnoea
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 01/23/21 and 02/13/2021. COVID + on 1/10/22. Presented to ED on 1/17/2022 with acute hypoxic respiratory failure 2/2 COVID-19 and needed 2L on admit. Presented with malaise and SOB x 1 week. Previously admitted on 1/10/22 and treated with Decadron. CXR showed worsening bilateral pulmonary opacities given Lasix and also received supplemental O2 via HFNC +NC. Code status changed to DNAR. Patient expired on 1/25/22
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Lung opacity, Malaise, SARS-CoV-2 test positive
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 01/23/21 and 02/13/2021. COVID + on 1/10/22. Presented to ED on 1/17/2022 with acute hypoxic respiratory failure 2/2 COVID-19 and needed 2L on admit. Presented with malaise and SOB x 1 week. Previously admitted on 1/10/22 and treated with Decadron. CXR showed worsening bilateral pulmonary opacities given Lasix and also received supplemental O2 via HFNC +NC. Code status changed to DNAR. Patient expired on 1/25/22
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: A 15-year-old patient given Moderna instead of Pfizer. Talked to patient's mom. There was no reaction to the vaccine. She is doing good, and mom is fine with Moderna.
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Dermatologic examination, Pityriasis lichenoides et varioliformis acuta, Rash
Clinical narrative: Diagnosed with Pityriasis lichenoides et varioliformis acuta (PLEVA), otherwise known as Mucha-Habermann disease approx.  14 days post vaccine. Symptoms: trunk rash that appeared out of nowhere Treatment- antibiotics for 2-3 months, steroid cream- can last for up to 1 year with reoccuring rash
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was diluted with sodium chloride 0.9% that had expired 1/1/22. Pfizer manufactured the diluent and had no stability data past expiration date, said in the absence of this data to re-dose the vaccine.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: 17 year old patient was given Child Pfizer vaccine  0.3 ml
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19, UNK
Symptoms: COVID-19, COVID-19 pneumonia, Death, Intensive care, Positive airway pressure therapy
Clinical narrative: Moderna COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccines on 07/17/21 and 08/14/2021. COVID + on 1/18/22. Presented to ED on 1/18/22. Admitted with respiratory distress and COVID PNA. Transferred to ICU on 1/19/22 due to worsening oxygenation status and maintained on BiPAP and then Airvo.  Code status changed to DNAR. During admission, patient treated with rocephin, azithromycin, zosyn, dexamethasone, and remdesivir. Patient wished to remove Airvo. Placed on comfort care on 1/25/22. Expired on 1/26/22.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19, UNK
Symptoms: Respiratory distress, SARS-CoV-2 test positive
Clinical narrative: Moderna COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccines on 07/17/21 and 08/14/2021. COVID + on 1/18/22. Presented to ED on 1/18/22. Admitted with respiratory distress and COVID PNA. Transferred to ICU on 1/19/22 due to worsening oxygenation status and maintained on BiPAP and then Airvo.  Code status changed to DNAR. During admission, patient treated with rocephin, azithromycin, zosyn, dexamethasone, and remdesivir. Patient wished to remove Airvo. Placed on comfort care on 1/25/22. Expired on 1/26/22.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was diluted with sodium chloride 0.9% that had expired 1/1/22. Pfizer manufactured the diluent and had no stability data past expiration date, said in the absence of this data to re-dose the vaccine.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac flutter, Cardiac monitoring, Chest discomfort, Pain, Paraesthesia
Clinical narrative: Most importantly, I now have persistent heart fluttering/murmuring as well as pain which seems to be in the kidneys...both issues I abjectly have NOT had my entire life. I am physically fit, I eat healthy, I have no family history of this stuff. Last week I counted over twenty noticeable heart flutterings/irregularities in the span of two days; every single day since 22 September has had heart fluttering, no exceptions. This morning I had a fluttering persist for over seven seconds.  I feel a weight in my chest if I relax on the couch to watch a movie, and breathing comes with effort (sporadically).   I was issued a 14 day heart monitor as-of today by the main hospital. Persistent fatigue from dose 1 still had not wore off, this made it worse. Furthermore, it also exacerbated poor circulation to all four limbs (persistent from dose 1) and a constant tingling sensation. This report is filed in conjunction with the one I just filled out regarding the first dose of the Pfizer vaccine, Temporary VAERS E-Report Number 792324.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Sudden hearing loss, Tinnitus
Clinical narrative: Vaccine given on 1/15/22. Sudden hearing loss and tinnitus developed 1/31/22. In right ear.  Went to immediate care on 2/3/2022 and prescribed Dexamethasone 4 mg twice daily which I am on my second day with no improvement.  Will be seeing ENT specialist on 2/10/2022.
Age: 8.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product preparation issue
Clinical narrative: No adverse effects have occurred yet, however the patient was given and undiluted dose of the pfizer pediatric covid vaccine.  Pt's mom will be monitoring her over the next several days and I will be following up with mom the next few days as well
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Condition aggravated, Cough, Dyspnoea
Clinical narrative: 20 minutes after receiving the vaccine, I had a dull headache and sore arm that gradually got worse as the day went on; I also had a red spot at the injection site. I had a fever, body aches, coughing and was down for about 3 days after the day of receiving my vaccine from exhaustion and fatigue. I had some shortness of breath as well. I went to urgent care on 01/10/2021 to test for COVID-19 from my symptoms, but the test came back negative. They also tested me for influenza and that came back positive. I received my second dose a month later and had the same exact symptoms from the first but didn't have the flu this time. I had a fever of 103 degrees, body aches and chills, extreme fatigue, and a dreading headache. I was down for about 3-5 days after the second dose. The symptoms went away and I returned to work. I never received the booster because I was sooo sick from the first and second doses. On 01/02/2022, I tested positive for COVID-19. My PCP prescribed me Protozone Cortisol and Z-tac, Benzonatate (Tessalon Perles), Albuterol inhaler and nebulizer. He also suggested Tylenol and cough syrup for the fever and cough I was having.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Illness, Impaired work ability, Influenza
Clinical narrative: 20 minutes after receiving the vaccine, I had a dull headache and sore arm that gradually got worse as the day went on; I also had a red spot at the injection site. I had a fever, body aches, coughing and was down for about 3 days after the day of receiving my vaccine from exhaustion and fatigue. I had some shortness of breath as well. I went to urgent care on 01/10/2021 to test for COVID-19 from my symptoms, but the test came back negative. They also tested me for influenza and that came back positive. I received my second dose a month later and had the same exact symptoms from the first but didn't have the flu this time. I had a fever of 103 degrees, body aches and chills, extreme fatigue, and a dreading headache. I was down for about 3-5 days after the second dose. The symptoms went away and I returned to work. I never received the booster because I was sooo sick from the first and second doses. On 01/02/2022, I tested positive for COVID-19. My PCP prescribed me Protozone Cortisol and Z-tac, Benzonatate (Tessalon Perles), Albuterol inhaler and nebulizer. He also suggested Tylenol and cough syrup for the fever and cough I was having.